Home Stock

Stock Research: bioMerieux

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

bioMerieux

ENXTPA:BIM FR0013280286
89
  • Value
    61
  • Growth
    47
  • Safety
    Safety
    81
  • Combined
    82
  • Sentiment
    78
  • 360° View
    360° View
    89
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

BioMerieux SA specializes in in-vitro diagnostics for medical and industrial applications. The company operates in the medical diagnostics and industrial analysis industries. It has subsidiaries in France, Germany, Austria, and other countries. In the last fiscal year, the company had a market cap of $16,227 million, profits of $2,294 million, and revenue of $4,120 million, with 14,754 employees.

more
Strongest Rank Price vs. Earnings (P/E)
Weakest Rank 360° View
Country France
Industry Health Care Equipment
Size Large
Website biomerieux.fr
Index
CAC All
SBF 120
Human Rights
Recycling
SDG 10
SDG 12
SDG 13
SDG 3
SDG 8
BioMerieux stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
61 62 67 77
Growth
47 70 31 25
Safety
Safety
81 93 90 85
Sentiment
78 88 65 79
360° View
360° View
89 100 86 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
46 47 59 69
Opinions Change
50 68 61 50
Pro Holdings
n/a 87 90 17
Market Pulse
73 73 18 92
Sentiment
78 88 65 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
61 62 67 77
Growth
47 70 31 25
Safety Safety
81 93 90 85
Combined
82 100 86 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
37 40 47 50
Price vs. Earnings (P/E)
53 52 52 72
Price vs. Book (P/B)
60 44 52 61
Dividend Yield
47 53 51 43
Value
61 62 67 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
41 60 42 16
Profit Growth
63 73 37 64
Capital Growth
41 56 34 37
Stock Returns
51 64 57 35
Growth
47 70 31 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
76 72 78 65
Refinancing
47 45 43 40
Liquidity
89 92 92 94
Safety Safety
81 93 90 85

Similar Stocks

Discover high‑ranked alternatives to bioMerieux and broaden your portfolio horizons.

Rubis

ENXTPA:RUI
Country: France
Industry: Gas Utilities
Size: Medium
Full Stock Analysis

Synergie

ENXTPA:SDG
Country: France
Industry: HR- & Employment Services
Size: Medium
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

ENGIE

ENXTPA:ENGI
Country: France
Industry: Multi-Utilities
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews